NCT01585740

Brief Summary

The objective of this study is to compare the effect on mean maternal and neonatal pH, and 24-hour postoperative morbidity, following intraoperative infusion of Ringer's Lactated versus normal saline in caesarean section at Mulago Hospital. The null hypothesis is that intraoperative infusion of Ringer's Lactate in caesarean section at Mulago Hospital will not result in 30% less mean maternal and neonatal pH change than intraoperative infusion of normal saline.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2011

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

April 5, 2012

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 26, 2012

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
Last Updated

June 14, 2012

Status Verified

June 1, 2012

Enrollment Period

7 months

First QC Date

April 5, 2012

Last Update Submit

June 13, 2012

Conditions

Keywords

Hyperchloraemic metabolic acidosisNeonatal acidosisNeonatal hyperchloraemiaBase excessMetabolic acidosisCaesarean sectionNormal salineRinger's LactatePostoperative morbidity

Outcome Measures

Primary Outcomes (1)

  • Change in Maternal pH from preoperative baseline

    The aim is to study the effect of the study fluid on maternal pH. pH will be measured preoperatively and immediately postoperatively before the patient leaves the recovery room.

    Intraoperatively

Secondary Outcomes (3)

  • Neonatal pH

    Within 30 seconds of umbilical cord ligature

  • Change in maternal base excess from preoperative baseline

    Intraoperatively

  • Number of mothers with postoperative morbidity events

    24 hours postoperatively

Study Arms (2)

Normal Saline

ACTIVE COMPARATOR

250 patients in this arm assigned to receive normal saline as the study fluid

Drug: 0.9% Normal Saline

Ringer's Lactate

ACTIVE COMPARATOR

250 patients in this arm assigned to receive Ringer's Lactate as the study fluid

Drug: Ringer's Lactate

Interventions

Crystalloid fluid

Also known as: Normal saline
Normal Saline

Crystalloid fluid

Also known as: Lactated Ringer's, Hartmann's Solution
Ringer's Lactate

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All parturients who consent for the study.
  • Up to American Society of Anesthesiology (ASA) class ІІ/E.

You may not qualify if:

  • Failed spinal anaesthesia that has to be converted to general anaesthesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mulago Hospital Labour Suite Operating Theatre

Kampala, Uganda

Location

Related Publications (1)

  • Ayebale ET, Kwizera A, Mijumbi C, Kizito S, Roche AM. Ringer's Lactate Versus Normal Saline in Urgent Cesarean Delivery in a Resource-Limited Setting: A Pragmatic Clinical Trial. Anesth Analg. 2017 Aug;125(2):533-539. doi: 10.1213/ANE.0000000000002229.

MeSH Terms

Conditions

Acidosis

Interventions

Saline SolutionRinger's Lactate

Condition Hierarchy (Ancestors)

Acid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Emmanuel T Ayebale, Anaesthesia

    Makerere University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Emmanuel Timarwa Ayebale

Study Record Dates

First Submitted

April 5, 2012

First Posted

April 26, 2012

Study Start

September 1, 2011

Primary Completion

April 1, 2012

Study Completion

May 1, 2012

Last Updated

June 14, 2012

Record last verified: 2012-06

Locations